Interstitial Assessment of Architectural Heterogeneity in Prostate Cancer Using a Fine Needle Photoacoustic Probe
Recruiting
Observational Study
Prostate Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 40 – 80
- Sex
- Male
- Study type
- Observational
- Participants needed
- 50 (estimated)
- Sponsor
- University of Michigan Rogel Cancer Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
In this project, we will integrate the Photoacoustic (PA) technology into a prostate biopsy procedure through a fine needle probe. The needle probe will be in the shape of a biopsy needle and compatible with the needle insertion mechanism in the transrectal ultrasound (TRUS) probe. When inserted into the prostate, the fine needle PA probe will assess the histological information in its surrounding…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* 1\) Planned prostate biopsy as part of routine clinical care
* 2\) \> 40 and \<80 years old
Exclusion Criteria:
* 1\) Known history of bleeding disorders or
* 2\) Patients taking anticoagulants, no matter doses or washout time
* 3\) Known allergy to silicone material
* 4\) U…
Contacts